Latest / Mesa News Today | 2 Min News | The Daily News Now!
FDA Peptide Review Sparks Legal Battle | Mesa News
The FDA is poised to ban popular compounded peptides—key players in longevity and wellness—sparking a high-stakes legal battle with EVEXIAS Life Sciences, who’s suing over what they call unjustified restrictions. These short amino acid chains, used for healing, sleep, and inflammation, are trending as alternatives to traditional medicine, but the FDA argues they lack proper safety oversight. Meanwhile, experts warn against risky online purchases, urging patients to seek regulated sources. The outcome could redefine the future of peptide-based treatments—balancing innovation with safety…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.